Tag: ATOS

Blue Horseshoe Stocks: MDCN Recap, Options Idea & More

Medican Enterprises, Inc. MDCN

In yesterday morning’s premarket report we took note of MDCN’s rebound off of a relative bottom, and speculated that the momentum built up in Tuesday’s session could carry over into added gains.

That certainly proved to be the case, as MDCN spiked heavily from its early low of .0024, running as high as .0039 shortly before 11:30AM. It marked an intraday move which provided gain opportunities of up to 62% before pulling back into the close of .0022.

We’ll go ahead and monitor this one for the remainder of the week for any potential bounce-play chances that might arise when it finds solid support. We’ll look for that to occur at or above Tuesday’s low of .0015.

Isis Pharmaceuticals, Inc. ISIS – Options Idea

ISIS appears to be in full-on breakout mode this morning, and as a result we thought we’d formulate an idea to take advantage of this via the options chain.

Given the current price and conditions caused by this morning’s catalyst (link to PR below), we’re going to be tracking the activity in the Weekly $70-73 Calls for potential intraday flip opportunities.

Extended Watchlist:
PTBI, RAD, SFUN, ATOS, AGEN, ASTI

Blue Horseshoe Stocks: CYBR, MCP, MEIP & More

CyberArk Software, Ltd. CYBR

Our first experiences with CYBR were good ones, when we successfully called a couple of potentially lucrative options trades around the middle of last month. It was in our report from February 13ththat we targeted CYBR $50 and $55 Calls, and that day we saw moves in those contracts of 72% and 165% respectively.
–
We flagged CYBR once again yesterday, which had previously been under several weeks of consolidation, yet was gapping up in the premarket. The stock did well in reversing its path, trading in a range from 50.79-55.03, and holding the majority of those gains into the close.

Our current options idea is going to be the 04/17 $50 Calls (Closed at 6.60 yesterday). Should CYBR reach its way back to the $60-level anytime in the next few weeks, the gains we see in those contracts will be quite substantial.

Molycorp, Inc. MCP

MCP appeared in yesterday’s extended watchlist and demonstrated a reversal of its own. We’re going to place MCP on more intensive watch as the week progresses, as it has the markings of a potential bottom play.

We’ve illustrated some of the key characteristics of the chart below, which appears to be gearing up for what could be a big swing. The stock ran well over a dollar at the beginning of last month, so the potential for rapid gains has certainly been demonstrated.

MEI Pharma, Inc. MEIP

We’ve also got an eye on MEIP after the stock was crushed down to a 52-week low yesterday, following the company’s announcement of the failure of its cancer drug in middle-stage testing.

A single-session depreciation on the order of 70% is the hallmark of one heck of a knee-jerk reaction, and the stock appears to be gapping up slightly this morning, so we’ll be on the lookout for a recovery in MEIP shares in coming days.

Extended Watchlist:
IMGN, ATOS ISR, HEB, GEVO, NEPT

Blue Horseshoe Stocks: Pharma Watchlist & More

Lexicon Pharmaceuticals, Inc. LXRX

We’re taking notice of LXRX this morning in the wake of a premarket PR that has the stock trending up to its highest levels of the past three months; it contained updates on current projects as well as increased earnings. The addition of an interesting setup on the chart gives us good reason to place LXRX on watch this mid-week.

As you can see on the snapshot below, the stock gapped down significantly at the end of November. In premarket activity today we’re seeing a partial fill taking place. We’re going to be watching for LXRX to fill the remainder of the gap into the mid 1.20’s where its next area of resistance will come in at the 200DMA of 1.28.

THE WOODLANDS, Texas, March 4, 2015 /PRNewswire/ — Lexicon Pharmaceuticals, Inc. (LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months and year ended December 31, 2014.>> VIEW PR

Pharmaceutical Watchlist

There are a number of other pharma and biopharma stocks gapping up in the premarket this morning, some of which have appeared in our reports in the past. We’ve listed them below along with links to today’s news, where applicable:

Keryx Biopharmaceuticals, Inc. KERX


Atossa Genetics, Inc. ATOS


Coronado Biosciences, Inc. CNDO

Coronado Biosciences Forms New Subsidiary, Checkpoint Therapeutics, to Develop Novel Immuno-Oncology Antibodies (Wed 8:30AM EST)

PhotoMedex, Inc. PHMD

Orexigen Therapeutics, Inc. OREX

KaloBios Pharmaceuticals, Inc. KBIO

Earnings-Related Options Ideas

American Eagle Outfitters, Inc. AEO beat expected Q4 profits and revenues, and is gapping up as a result. To take advantage of the trend, we are monitoring options trading possibilities in the AEO Weekly $15-16 Calls

Abercrombie & Fitch ANF fell short of expectations with regard to sales, which is fueling a downtrend here in the premarket, so we’ll take the opposite approach here, and keep an eye on ANF Weekly $23-24 Puts.

Extended Watchlist:
IFON, PLUG, NPTN, WLT, LEI

Blue Horseshoe Stocks: EYES, BIOC Recaps, RSHCQ & More

Biocept, Inc. BIOC

BIOC continued to roll for the third straight day yesterday since we tagged the play in Monday’s extended watchlist. We witnessed a trading ramnge from 3.90-4.91, which marked an intraday move of 26% on nearly 12x its monthly average volume.

Calculated from the low of 1.71 which we observed on Monday, yesterday’s high represented an overall increase of 187% in a span of just three sessions.

Second Sight Medical Products, Inc.  EYES

We added EYES into the mix in Tuesday’s report, and it too continued to trend up yesterday. The stock traded in a daily range from 11.25 to 14.75, a healthy 31% intraday run.

From our observed low of 9.55 on Tuesday, yesterday’s high was equal to a 54% session-over-session move.

RadioShack Corp. RSHCQ

We want to update our readers on RadioShack today, which despite its ongoing bankruptcy proceedings, has been a winning selection for us this year. We first jumped on it in our report published on the morning of February 9th, whereupon we witnessed a low of .1251 and on Tuesday, the stock hit .37, which comes out to a twelve-session increase of 196%

Yesterday we received word of the approval from a U.S. Bankruptcy Court judge to auction off roughly 2,000 RadioShack stores, with an initial bid of $200M having been entered by the Standard General hedge fund.

Lawyers for RadioShack claim that the company has received bids on the leases of more than 200 of the 1,100 locations slated for immediate shutdown, including interest from a unit of GameStop Corp. >> View Article

We’ll be interested to monitoring RSHCQ as events continue to unfold in coming weeks.

Yesterday’s Extended Watchlist Movers 

We also had a number of plays from yesterday’s extended watchlist make notable moves:

Legend Oil & Gas, Ltd. LOGL enjoyed an early pop, running straight out of the gate from a low of .0038 to as high as .0049; good enough for a quick intraday scalp of up to 29%

BenefitFocus, Inc. BNFT produced a substantial spike for a stock trading in its price range, rising steadily from its low 32.15 to hit 37.94, a gain of 18%

SFX Entertainment, Inc. SFXE also recorded a modest intraday increase of 14% as it traded in a range from 4.36 to 4.95. It’s worth mentioning that while the CEO of SFXE is attempting to take the company private, the board has come under investigation regarding the equitability of the proposed terms of that deal. Anyone considering SFXE should make themselves fully aware of that situation as it unfolds. >>> GO TO PR

Extended Watchlist:
ELX, PVA, ATOS, FRO, NXTD, GOGO(Signed deal with Delta)

Blue Horseshoe Stocks: WATT Recap & More

Energous Corp.  WATT

WATT was included in our extended watchlist on Wednesday before the holiday break, and the stock went on to make a modest yet solid move, despite having only a short session in which to do so. We saw the stock rise from an early low of 8.40 on up to a high of 9.50, which represents an intraday spike of 13%

Apart from its bullish chart, one of the main reasons that WATT is so interesting is that its “WattUp” technology is so close to the cutting edge. Wireless charging has gained a fair bit of steam with charging mats over the past several years, but those require that the device be sitting on the pad. A technology that can rout power wirelessly over a much larger area has yet to make its way to the mainstream.

We’ll be keeping watch over WATT, which could really make a splash if the WattUp technology proves to be as versatile and efficient as the company claims, and is able to clear FCC Certification for which it is currently undergoing tests. >> LEARN MORE ABOUT THE TECHNOLOGY

Extended Watchlist:
ANV, AUY, ATOS, NOG

Get Our FREE Daily Reports!

SUBSCRIBE